Quality Leadership: The Challenge and Opportunity Facing CMS Nominee Berwick
This article was originally published in RPM Report
Institute for Healthcare Improvement CEO Don Berwick is the pick to run CMS during the health care reform implementation period. If confirmed, he will have a golden opportunity to try out quality improvement ideas on a national stage.
You may also be interested in...
The health care reform debate was wild and wooly-but it is hard to imagine a better outcome for the biopharma sector in general and the Pharmaceutical Research & Manufacturers of America in particular. So why isn't anybody celebrating?
The drama of the health care reform debate is undeniable, but that doesn’t mean it’s easy to see how it will change the business of drug development. But it will, and we’ll give you 10 reasons why.
There are multiple political strategies playing out in Washington on health care reform that will directly impact the biopharma industry. In the end biopharma will trade margins for volume. The RPM Report makes predictions on what will make it into the final health reform bill.